September 12, 2013
Merck Serono launched on September 9 its recombinant human growth hormone preparation Saizen 12 mg Subcutaneous Injection (recombinant somatropin) for the treatment of short stature associated with growth hormone deficiency. The product is a ready-to-use solution for injection. It has...read more